| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines
|
Juan-Giner, Aitana
|
|
|
24 |
6 |
p. 562-564
|
artikel
|
| 2 |
Alasdair Macintosh Geddes
|
Venkatesan, Priya
|
|
|
24 |
6 |
p. 577
|
artikel
|
| 3 |
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia
|
Gunale, Bhagwat
|
|
|
24 |
6 |
p. 639-649
|
artikel
|
| 4 |
A novel dual targeted antibacterial agent for Helicobacter pylori
|
Chen, Jinnan
|
|
|
24 |
6 |
p. 569-570
|
artikel
|
| 5 |
An 80-year-old woman with severe pruritic erythematous and hyperkeratotic plaques
|
Chen, Xi-Bei
|
|
|
24 |
6 |
p. e415
|
artikel
|
| 6 |
A simplified vaccine for cholera outbreak control
|
The Lancet Infectious Diseases,
|
|
|
24 |
6 |
p. 557
|
artikel
|
| 7 |
Bivalent (Omicron BA.5/ancestral) recombinant spike protein vaccine: a promising booster
|
Zhang, Ruiqi
|
|
|
24 |
6 |
p. 558-559
|
artikel
|
| 8 |
Brazil's dengue vaccine campaign falters
|
Triunfol, Marcia
|
|
|
24 |
6 |
p. e358
|
artikel
|
| 9 |
Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo
|
Coulborn, Rebecca M
|
|
|
24 |
6 |
p. 602-610
|
artikel
|
| 10 |
Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam
|
Adamson, Paul C
|
|
|
24 |
6 |
p. e351-e352
|
artikel
|
| 11 |
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic review
|
Anyiwe, Kikanwa
|
|
|
24 |
6 |
p. e366-e385
|
artikel
|
| 12 |
Combining vaccines, optimised supportive care, and therapeutics for Ebola virus disease increases survival
|
Fischer II, William A
|
|
|
24 |
6 |
p. 560-562
|
artikel
|
| 13 |
Community perspectives on abortion in eastern South Africa
|
Warren, Sylvia
|
|
|
24 |
6 |
p. 579
|
artikel
|
| 14 |
Correction to Lancet Infect Dis 2019; 19: 1380
|
|
|
|
24 |
6 |
p. e356
|
artikel
|
| 15 |
Correction to Lancet Infect Dis 2024; published online Feb 1. https://doi.org/10.1016/S1473-3099(23)00706-5
|
|
|
|
24 |
6 |
p. e356
|
artikel
|
| 16 |
Correction to Lancet Infect Dis 2024; published online Feb 8. https://doi.org/10.1016/S1473-3099(24)00062-8
|
|
|
|
24 |
6 |
p. e356
|
artikel
|
| 17 |
Correction to Lancet Infect Dis 2024; published online March 22. https://doi.org/10.1016/S1473-3099(24)00154-3
|
|
|
|
24 |
6 |
p. e356
|
artikel
|
| 18 |
Effectiveness of pyriproxyfen-pyrethroid and chlorfenapyr-pyrethroid long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs for malaria control in the third year post-distribution: a secondary analysis of a cluster-randomised controlled trial in Benin
|
Accrombessi, Manfred
|
|
|
24 |
6 |
p. 619-628
|
artikel
|
| 19 |
Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial
|
dos Santos, Paulo Cesar Pereira
|
|
|
24 |
6 |
p. 594-601
|
artikel
|
| 20 |
Family and sexual behaviour in South Africa
|
Sherwood-Martin, Hollie
|
|
|
24 |
6 |
p. 580
|
artikel
|
| 21 |
Global action to improve access to tools for cholera
|
Jesudason, Timothy
|
|
|
24 |
6 |
p. e361
|
artikel
|
| 22 |
Highlights of ESCMID Global 2024
|
Hall, Phoebe
|
|
|
24 |
6 |
p. e357
|
artikel
|
| 23 |
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
|
Bennett, Chijioke
|
|
|
24 |
6 |
p. 581-593
|
artikel
|
| 24 |
Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study
|
Doshi, Reena H
|
|
|
24 |
6 |
p. 611-618
|
artikel
|
| 25 |
Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1
|
Wannigama, Dhammika Leshan
|
|
|
24 |
6 |
p. e348-e350
|
artikel
|
| 26 |
Infectious disease surveillance update
|
Islam, Tanzina
|
|
|
24 |
6 |
p. e364
|
artikel
|
| 27 |
Is a therapeutic dengue monoclonal antibody on the way?
|
Ooi, Eng Eong
|
|
|
24 |
6 |
p. 567-568
|
artikel
|
| 28 |
Is the next generation of mosquito nets surviving expectations?
|
Moore, Sarah
|
|
|
24 |
6 |
p. 564-565
|
artikel
|
| 29 |
Kenneth Ira Berns
|
Bagcchi, Sanjeet
|
|
|
24 |
6 |
p. 576
|
artikel
|
| 30 |
Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study
|
Brito, Marcelo
|
|
|
24 |
6 |
p. 629-638
|
artikel
|
| 31 |
Pertussis outbreak in Czech Republic
|
Holt, Ed
|
|
|
24 |
6 |
p. e359
|
artikel
|
| 32 |
Plasma-based antigen persistence in the post-acute phase of COVID-19
|
Peluso, Michael J
|
|
|
24 |
6 |
p. e345-e347
|
artikel
|
| 33 |
Prevention of congenital syphilis within antenatal PrEP services in South Africa: missed opportunities
|
Joseph Davey, Dvora
|
|
|
24 |
6 |
p. 571-572
|
artikel
|
| 34 |
Progress towards safer and more effective radical cure of Plasmodium vivax
|
Price, Ric N
|
|
|
24 |
6 |
p. 565-567
|
artikel
|
| 35 |
Reducing risks from respiratory pathogens at the 2024 Hajj
|
Memish, Ziad A
|
|
|
24 |
6 |
p. 573-575
|
artikel
|
| 36 |
Reporting of deaths during cholera outbreaks: case fatality ratio and community deaths
|
Finger, Flavio
|
|
|
24 |
6 |
p. e353
|
artikel
|
| 37 |
Research in brief
|
Venkatesan, Priya
|
|
|
24 |
6 |
p. e365
|
artikel
|
| 38 |
Revaccination with BCG: does it work?
|
McShane, Helen
|
|
|
24 |
6 |
p. 559-560
|
artikel
|
| 39 |
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials
|
Li, Xiaojiao
|
|
|
24 |
6 |
p. 650-664
|
artikel
|
| 40 |
Shifting transmission patterns of human mpox in South Kivu, DR Congo
|
Katoto, Patrick DMC
|
|
|
24 |
6 |
p. e354-e355
|
artikel
|
| 41 |
The global burden of fracture-related infection: can we do better?
|
Metsemakers, Willem-Jan
|
|
|
24 |
6 |
p. e386-e393
|
artikel
|
| 42 |
Theresa Ochoa—staying on top of infectious diseases in Peru
|
Kirby, Tony
|
|
|
24 |
6 |
p. 578
|
artikel
|
| 43 |
The role of asymptomatic infections in influenza transmission: what do we really know
|
Montgomery, Martha P
|
|
|
24 |
6 |
p. e394-e404
|
artikel
|
| 44 |
Transjugular intrahepatic portosystemic shunt followed by splenectomy for complicated hepatosplenic schistosomiasis: a case report and review of the literature
|
Tamarozzi, Francesca
|
|
|
24 |
6 |
p. e405-e414
|
artikel
|
| 45 |
WHO's 2024 global hepatitis report
|
Burki, Talha
|
|
|
24 |
6 |
p. e362-e363
|
artikel
|
| 46 |
WHO's 2024 guidelines to combat hepatitis B
|
Bagcchi, Sanjeet
|
|
|
24 |
6 |
p. e360
|
artikel
|
| 47 |
Zoonotic tuberculosis in the 21st century
|
Dean, Anna S
|
|
|
24 |
6 |
p. e344
|
artikel
|
Tijdschrift beschrijving